The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Focal Prostate Cryoablation: Initial Results Show Cancer Control and Potency Preservation
Abstract
BACKGROUND: Focal prostate cryoablation is the less-than-complete ablation of the gland with ice. Known tumor is ablated aggressively, whereas contralateral prostate tissue and surrounding structures are spared. This method offers targeted local cancer control aiming at sexual potency and urinary continence preservation in patients whose prostate cancer is believed to be unilateral. PATIENTS AND METHODS: Patients who had a strong desire for preservation of sexual function and continence were informed of focal prostate cryoablation as an investigational treatment option for clinically organ-confined, unilateral tumor identified by color Doppler ultrasonography and confirmed by targeted and systematic biopsy. Only stage, not preoperative serum prostate specific antigen concentration (PSA) or tumor differentiation, was considered a potential contraindication. Thirty-one men with a mean age of 63 years underwent the procedure. Follow-up consisted of PSA measurement every 3 months for 1 year and every 6 months thereafter, with biopsies at 6 months and 1, 2, and 5 years and following any three consecutive PSA rises. Potency was determined with a patient questionnaire filled in without the physician present. RESULTS: At a mean follow-up of 70 months, biochemical disease-free status, according to the ASTRO definition, was maintained by 92.8% of patients (26/28) and a 96.0% negative-biopsy rate (24/25) was observed. The one biopsy-positive patient was subsequently treated with full-gland cryoablation and remains disease free. Potency was maintained by 48.1% of patients (13/27) and another 40.7% (11/27) were potent with oral pharmaceutical assistance, yielding a total potency-preservation rate of 88.9%. No complications were observed. CONCLUSION: Focal cryoablation can provide biochemical and local control of prostate cancer while preserving potency and continence. Further investigation is needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nerve Sparing Radical Prostatectomy: A Different View
Geary, E. S., Dendinger, T. E., Freiha, F. S., & Stamey, T. A. (1995) · Journal of Urology · doi:10.1016/s0022-5347(01)67251-3 · Cited by 189
Cited by
Thompson, R. H., Boorjian, S. A., Lohse, C. M., Leibovich, B. C., Kwon, E. D., Cheville, J. C., & Blute, M. L. (2008) · Journal of Urology · doi:10.1016/j.juro.2007.09.077 · Cited by 713
The Role of Focal Therapy in the Management of Localised Prostate Cancer: A Systematic Review
Valerio, M., Ahmed, H. U., Emberton, M., Lawrentschuk, N., Lazzeri, M., Montironi, R., Nguyen, P. L., Trachtenberg, J., & Polascik, T. J. (2014) · European Urology · doi:10.1016/j.eururo.2013.05.048 · Cited by 369
New and Established Technology in Focal Ablation of the Prostate: A Systematic Review
Valerio, M., Cerantola, Y., Eggener, S. E., Lepor, H., Polascik, T. J., Villers, A., & Emberton, M. (2017) · European Urology · doi:10.1016/j.eururo.2016.08.044 · Cited by 300
Metadata
- Authors
- Bahn, D. K., Silverman, P., Lee, F., Badalament, R., Bahn, E. D., & Rewcastle, J. C.
- Venue
- Journal of Endourology
- Publisher
- SAGE Publications
- Published
- 2006-09
- Volume
- 20
- Issue
- 9
- Pages
- 688-692
- ISSN
- 0892-7790 (ISSN-L)
- 1557-900X
- OpenAlex
- W2147599714
- Cited by
- 183
- References
- 1
- FWCI
- 11.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Focal Prostate Cryoablation: Initial Results Show Cancer Control and Potency Preservation. https://app.cochat.ai/papers/10.1089/end.2006.20.688
- The paper
- Bahn, D. K., Silverman, P., Lee, F., Badalament, R., Bahn, E. D., & Rewcastle, J. C. (2006). Focal Prostate Cryoablation: Initial Results Show Cancer Control and Potency Preservation. Journal of Endourology. https://doi.org/10.1089/end.2006.20.688
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.